Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-06-18

Clinical Trial Update: Avenir Complete Post-Market Clinical Follow-Up Study [NA]

View source ↗

Summary

Zimmer Biomet's Avenir Complete post-market clinical follow-up study is active but not recruiting, monitoring patients with hip osteoarthritis and avascular nec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Avenir Complete

Snippet

Sponsor: Zimmer Biomet | Conditions: Osteoarthritis, Hip, Avascular Necrosis of Hip | NA | Status: ACTIVE_NOT_RECRUITING